Christopher Frantz
Impact in
- Neurology top 2%
- Neuroblastoma Research and Treatments
-
- Lymphoma Diagnosis and Treatment
Papers in
- Neurology 16
- Neuroblastoma Research and Treatments 15
-
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- Francisco ArguelloRaymond B. BaggsH.V. MallingStephen E. SallanCharles D. ScherLynne V. AbruzzoMark RaffeldMozhgan Kaviani
- Journals
- Journal of Clinical Oncology (4 papers)PEDIATRICS (3 papers)Journal of Cellular Physiology (2 papers)Molecular Cancer Therapeutics (2 papers)Blood (2 papers)
- Partner nations
- United StatesSwitzerlandTunisia
In The Last Decade
Christopher Frantz
52 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 109
- Neurology 448
- Pathology and Forensic Medicine 415
- Oncology 628
- Cancer Research 321
- Genetics 208
Countries citing papers authored by Christopher Frantz
This map shows the geographic impact of Christopher Frantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Frantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Frantz more than expected).
Fields of papers citing papers by Christopher Frantz
This network shows the impact of papers produced by Christopher Frantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Frantz. The network helps show where Christopher Frantz may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Frantz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2023 | 12 | |
| 3 | Functional and Ultrastructural Assessment of Novel OCT Findings in the Cynomolgus Monkey | 2019 | 1 |
| 4 | 2013 | 13 | |
| 5 | 2011 | 6 | |
| 6 | 2010 | 15 | |
| 7 | 2006 | 7 | |
| 8 | 2005 | 59 | |
| 9 | 1999 | 11 | |
| 10 | 1998 | 9 | |
| 11 | 1993 | 18 | |
| 12 | 1992 | 39 | |
| 13 | Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow. | 1991 | 3 |
| 14 | In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. | 1989 | 113 |
| 15 | 1986 | 3 | |
| 16 | 1978 | 2 | |
| 17 | 1976 | 15 | |
| 18 | 1974 | 22 | |
| 19 | 1974 | 42 | |
| 20 | 1973 | 36 |
About Christopher Frantz
Christopher Frantz is a scholar working on Neurology, Cancer Research, Oncology, Genetics and Cell Biology, having authored 53 papers that have together received 2.1k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (15 papers), Cancer, Hypoxia, and Metabolism (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Hemoglobin structure and function (4 papers), Glycosylation and Glycoproteins Research (4 papers), Lung Cancer Research Studies (4 papers), Viral-associated cancers and disorders (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Neurology (448 citations), Pathology and Forensic Medicine (415 citations), Oncology (628 citations), Cancer Research (321 citations) and Genetics (208 citations). Christopher Frantz has collaborated with scholars based in United States, Switzerland and Tunisia. Frequent co-authors include Francisco Arguello, Raymond B. Baggs, H.V. Malling, Stephen E. Sallan, Charles D. Scher, Lynne V. Abruzzo, Mark Raffeld, Mozhgan Kaviani, ES Jaffe and Charles D. Stiles. Their work appears in journals such as Journal of Clinical Oncology, PEDIATRICS, Journal of Cellular Physiology, Molecular Cancer Therapeutics and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.